SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023269
Filing Date
2022-11-08
Accepted
2022-11-08 16:31:08
Documents
66
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avro-20220930.htm   iXBRL 10-Q 2605368
2 EX-31.1 avro-ex31_1.htm EX-31.1 20532
3 EX-31.2 avro-ex31_2.htm EX-31.2 20537
4 EX-32.1 avro-ex32_1.htm EX-32.1 18096
  Complete submission text file 0000950170-22-023269.txt   7539359

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avro-20220930.xsd EX-101.SCH 44537
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avro-20220930_def.xml EX-101.DEF 121436
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avro-20220930_pre.xml EX-101.PRE 247448
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avro-20220930_lab.xml EX-101.LAB 353501
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avro-20220930_cal.xml EX-101.CAL 32970
60 EXTRACTED XBRL INSTANCE DOCUMENT avro-20220930_htm.xml XML 1237744
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 221369386
SIC: 2836 Biological Products, (No Diagnostic Substances)